Post-market European & Asian Registry to Evaluate the Minos™ Stent-Graft and Delivery System in Abdominal Aortic Aneurysm Treatment
This trial has no sites in United States.
It has sites in 6 countries. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd
- Trial code
- NCT07674173
- Record updated
- 29 June 2026
- Original description
The Minos™ Abdominal Aortic Stent-Graft and Delivery System is a medical device designed to treat abdominal aortic aneurysms using a minimally invasive procedure. The device is placed inside the aorta through blood vessels, usually accessed through small incisions in the groin. The goal of this observational study is to collect short-, medium- to long-term safety and performance data of the Minos™ stent-graft in everyday medical practice (real-world settings). The aim is to study about 200 patients worldwide and at least 30 patients in European hospitals.Read full original descriptionShow less
A Prospective Multi-centre Observational Real-world Post-market European & Asian Registry With Low-profile Minos™ Abdominal Aortic Stent Graft
The Minos™ Abdominal Aortic Stent-Graft and Delivery System is a medical device designed to treat abdominal aortic aneurysms using a minimally invasive procedure. The device is placed inside the aorta through blood vessels, usually accessed through small incisions in the groin. The goal of this observational study is to collect short-, medium- to long-term safety and performance data of the Minos™ stent-graft in everyday medical practice (real-world settings). The aim is to study about 200 patients worldwide and at least 30 patients in European hospitals.
Inclusion: Diagnosis of infrarenal abdominal aortic aneurysm; Plan to treat with Minos Abdominal Aortic Stent-Graft and Delivery System; Voluntary participation and completion of Informed Consent Form, with willingness to participate in follow-up to 5 years post-procedure.
Exclusion: Subjects who are considered not suitable for treatment with stent graft; Those who are allergic to contrast agents or unable to tolerate contrast agents due to renal insufficiency; Patients with severe coagulation disorder and/or high risk of postoperative hemorrhage; Subjects with connective tissue diseases, such as Marfan syndrome; Subjects who are allergic to nitinol; Subjects in whom use of the Minos™ Abdominal Aortic Stent-Graft and Delivery System is contraindicated, as follows:; Severe stenosis or calcification near the aneurysm, leading to difficulty in achieving apposition of vessel wall and stent graft; Difficult access due to severe stenosis or tortuosity in the iliac artery or femoral artery; Subjects with ruptured aneurysm or acute aneurysm; Subjects with an infectious aneurysm; Aneurysmal neck angulation greater than 60°; Patients with blood supply to vital organs originating from the aneurysmal sac; Patients with other comorbidities and whose life expectancy does not exceed one year; Minors and pregnant women.